Shortened survival after relapse in T-cell acute lymphoblastic leukemia patients with p16/p15 deletions

Leukemia Research

Volumn 21, Issue 6, 1997, Pages 549-558

  Diccianni, Mitchell B ^a   Batova, Ayse ^a   Yu, John ^b   Vu, Thai ^a   Pullen, Jeanette ^c   Amylon, Michael ^d   Pollock, Brad H ^e   Yu, Alice L ^a  

^a UCSD MEDICAL CENTER   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF MISSISSIPPI   (United States)

^d STANFORD UNIVERSITY   (United States)

^e POG Statistical Office   (United States)

Author keywords

p15; p16; p18; Prognosis; Relapse; T ALL

Indexed keywords

CYCLIN DEPENDENT KINASE; PROTEIN P16;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; DELETION MUTANT; GENE LOSS; HOMOZYGOSITY; HUMAN; HUMAN CELL; LEUKEMIA REMISSION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MEDIASTINUM MASS; PRIORITY JOURNAL; T CELL LEUKEMIA;

CARRIER PROTEINS; CELL CYCLE PROTEINS; CYCLIN-DEPENDENT KINASE INHIBITOR P15; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DISEASE-FREE SURVIVAL; GENE DELETION; GENES, P53; GERM-LINE MUTATION; HETEROZYGOTE; HOMOZYGOTE; HUMANS; LEUKEMIA, T-CELL, ACUTE; POINT MUTATION; RECURRENCE; TUMOR SUPPRESSOR PROTEINS;

EID: 0030929927     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(97)00007-6     Document Type: Article

References (32)

1. Sherr, C. J., Mammalian G1 cyclins. Cell, 1993, 73, 1069.
2. Hartwell, L., Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells. Cell, 1992, 71, 543.
3. Nurse, P., Universal control mechanism regulating onset of M-phase. Nature, 1990, 344, 503.
4. Tam, S. W., Shay, J. W. and Pagano, M., Differential expression and cell cycle regulation of the cyclin-dependent kinase 4 inhibitor p16Ink4. Cancer Research, 1994, 54, 5816.
5. El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W. and Vogelstein, B., WAF1, a potential mediator of p53 tumor suppression. Cell, 1993, 75, 817.
6. Harper, J. W., Adami, G. R., Wei, N., Keyomarsi, K. and Elledge, S. J., The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell, 1993, 75, 805.
7. Diccianni, M. B., Yu, J., Hsiao, M., Mukherjee, S., Shao, L. E. and Yu, A. L., Clinical significance of p53 mutations in relapsed T-cell acute lymphoblastic leukemia. Blood, 1994, 84, 3105.
8. Serrano, M., Hannon, G. J. and Beach, D., A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature, 1993, 366, 704.
9. Hannon, G. J. and Beach, D., p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest. Nature, 1994, 371, 257.
10. Polyak, K., Lee, M. H., Erdjument-Bromage, H., Koff, A., Roberts, J. M., Tempst, P. and Massague, J., Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell, 1994, 78, 59.
11. Xiong, Y., Hannon, G. J., Zhang, H., Casso, D., Kobayashi, R. and Beach, D., p21 is a universal inhibitor of cyclin kinases. Nature, 1993, 366, 701.
12. Guan, K. L., Jenkins, C. W., Li, Y., Nichols, M. A., Wu, X., O'Keefe, C. L., Matera, A. G. and Xiong, Y., Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/ MTS2-related CDK6 inhibitor, correlates with wild-type pRb function. Genes & Development, 1994, 8, 2939.
13. Murphy, S. B., Raimondi, S. C., Rivera, G. K., Crone, M., Dodge, R. K., Behm, F. G., Pui, C.-H. and Williams, D. L., Nonrandom abnormalities of chromosome 9p in childhood acute lymphoblastic leukemia: association with high-risk clinical features. Blood, 1989, 74, 409.
14. Nobori, T., Miura, K., Wu, D. J., Lois, A., Takabayashi, K. and Carson, D. A., Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature, 1994, 368, 753.
15. Kamb, A., Gruis, N. A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S. V., Stockert, E., Day, R. S. III, Johnson, B. D. and Skolnick, M. H., A cell cycle regulator potentially involved in genesis of many tumor types. Science, 1994, 264, 436.
16. Jen, J., Harper, J. W., Bigner, S. H., Bigner, D. D., Papadopoulos, N., Markowitz, S., Willson, J. K. V., Kinzler, K. W. and Vogelstein, B., Deletion of p16 and p15 genes in brain tumors. Cancer Research, 1994, 54, 6353.
17. Caldas, C., Hahn, S. A., da Costa, L. T., Redston, M. S., Schutte, M., Seymour, A. B., Weinstein, C. L., Hruban, R. H., Yeo, C. J. and Kern, S. E., Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma. Nature Genetics, 1994, 8, 27.
18. Cheng, J. Q., Jhanwar, S. C., Klein, W. M., Bell, D. W., Lee, W. C., Altomare, D. A., Nobori, T., Olopade Ol, O., Buckler, A. J. and Testa, J. R., p16 alterations and deletion mapping of 9p21-p22 in malignant mesothelioma. Cancer Research, 1994, 54, 5547.
19. Okamoto, A., Hussain, S. P., Hagiwara, K., Spillare, E. A., Rusin, M. R., Demetrick, D. J., Serano, M., Hannon, G. J., Shiseki, M., Zariwala, M., Xiong, Y., Beach, D. H., Yokota, J. and Harris, C. C., Mutations in the p16INK4/ MTS1/CDKN2, p15INK4B/MTS2, and p18 genes in primary and metastatic lung cancer. Cancer Research, 1995, 55, 1448.
20. Diccianni, M. B., Chau, L. S., Batova, A., Vu, T. and Yu, A. L., The p16 and p18 tumor suppressor genes in neuroblastoma: implications for drug resistance. Cancer Letters, 1996, 104, 183.
21. Mon, T., Miura, K., Aoki, T., Nishihira, T., Mori, S. and Nakamura, Y., Frequent somatic mutation of the MTS1/ CDK4I (multiple tumor suppressor/cyclin-dependent kinase 4 inhibitor) gene in esophageal squamous cell carcinoma. Cancer Research, 1994, 54, 3396.
22. Koh, J., Enders, G. H., Dynlacht, B. D. and Harlow, E., Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibition. Nature, 1995, 375, 506.
23. Batova, A., Diccianni, M. B., Nobori, T., Vu, T., Bridgeman, L. and Yu, A. L., Frequent deletions in the methylthioadenosine phosphorylase gene in T-cell acute lymphoblastic leukemia: strategies for enzyme-target therapy. Blood, 1996, 88, 3083.
24. Batova, A., Diccianni, M. B., Yu, J. C., Nobori, T., Link, M. P., Pullen, J. and Yu, A. L., Frequent and selective methylation of p15 and deletion of both p15 and p16 in T-cell acute lymphoblastic (T-ALL). Cancer Research, 1996, 57, 832.
25. Fizzotti, M., Cimino, G., Pisegna, S., Alimena, G., Quartarone, C., Mandelli, F., Pelicci, P. G. and Lo Coco, F., Detection of homozygous deletions of the cyclin-dependent kinase 4 inhibitor (p16) gene in acute lymphoblastic leukemia and association with adverse prognostic features. Blood, 1995, 85, 2685.
26. Otsuki, T., Clark, H. M., Wellmann, A., Jaffe, E. S. and Raffeld, M., Involvement of CDKN2 (p16INK4AMTS1) and p15INK4B/MTS2 in human leukemias and lytnphomas. Cancer Research, 1995, 55, 1436.
27. Gombart, A. F., Morosetti, R., Miller, C. W., Said, J. W. and Koeffler, H. P., Deletions of the cyclin-dependent kinase inhibitor genes p16INK4A and p15INK4B in non-Hodgkin's lymphomas. Blood, 1995, 86, 1534.
28. Cayuela, J. M., Hebert, J. and Sigaux, F., Homozygous MTS1 (p16INK4A) deletion in primary tumor cells of 163 leukemic patients. Blood, 1995, 85, 854.
29. Hebert, J., Cayuela, J. M., Berkeley, J. and Sigaux, F., Candidate tumor-suppressor genes MTS1 (p16INK4A) and MTS2 (p15INK4B) display frequent homozygous deletions in primary cells from T- but not from B-cell lineage acute lymphoblastic leukemias. Blood, 1994, 84, 4038.
30. Ohnishi, H., Kawamura, M., Ida, K., Sheng, X. M., Hanada, R., Nobori, T., Yamamori, S. and Hayashi, Y., Homozygous deletions of p16/MTS1 gene are frequent but mutations are infrequent in childhood T-cell acute lymphoblastic leukemia. Blood, 1995, 86, 1269.
31. Okuda, T., Shurtleff, S. A., Valentine, M. B., Raimondi, S. C., Head, D. R., Behm, F., Curcio-Brint, A. M., Liu, Q., Pui, C-H., Sherr, C. J., Beach, D., Look, A. T. and Downing, J. R., Frequent deletion of p16INK4a/MTS1 and p15INK4b/MTS2 in pediatric acute lymphoblastic leukemia. Blood, 1995, 85, 2321.
32. Takeuchi, S., Bartram, C. R., Seriu, T., Miller, C. W., Tobler, A., Janssen, J. W. G., Reiter, A., Ludwig, W.-D., Zimmermann, M., Schwaller, J., Lee, E., Miyoshi, I. and Koeffler, H. P., Analysis of a family of cyclin-dependent kinase inhibitors: p15/MTS2/INK4B, p16/MTS1/INK4A, and p18 genes in acute lymphoblastic leukemia of childhood. Blood, 1995, 86, 755.